Project Grant R01DA066823
Award Date 8/15/26
Completion Date 5/31/31
Dollars Obligated $1.4M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Emigration Canyon, UT 84108, USA
Similar Awards
- The National Institute on Drug Abuse awarded the University of Utah $107,188 on August 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct a retrospective analysis of telehealth prescribing patterns and veteran health outcomes related to opioid and stimulant use disorders. The recipient will evaluate opioid- and stimulant-related morbidity and mortality among veterans who received prescriptions through the Veterans Health Administration between 2020 and 2025....
- The National Institute on Drug Abuse awarded $709,085 to The Regents of the University of Colorado, doing business as University of Colorado-Denver, on April 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279). The award funds an implementation trial testing in-hospital opioid treatment program (OTP) intakes to facilitate linkage from hospitalization to outpatient methadone treatment among patients with opioid use disorder. The study uses a staircase cluster randomized...
- The National Institute on Drug Abuse awarded the University of Utah $162,200 on October 10, 2025, under the Drug Use and Addiction Research Programs (CFDA 93.279) to characterize pain embodiment and its relationship to opioid misuse risk in chronic pain using neuroimaging. The award funds a five-year research project through September 30, 2030, performed in Salt Lake City, Utah. The research will employ resting-state functional magnetic resonance imaging to study pain embodiment—the tendency...
- The National Institute on Drug Abuse awarded the University of Pittsburgh $701,569 on September 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct research on the use and effectiveness of medications for opioid use disorder in older adults with multimorbidity. The award funds quantitative studies of Medicare and Veterans Health Administration enrollees with diagnosed opioid use disorder and a qualitative study of older adults with opioid use disorder and...
- The National Institute on Drug Abuse awarded the Board of Regents of Nevada System of Higher Education (University of Nevada, Reno) $402,205 on May 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279). The award funds a research study examining medication for opioid use disorder (MOUD) access and treatment outcomes among individuals dually enrolled in Medicare and Medicaid. The research uses Medicare Advantage utilization and prescription claims data from 2021–2024 alongside...
- The National Institute on Drug Abuse, a component of the Department of Health and Human Services National Institutes of Health, awarded the University of Utah $154,536 on August 20, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct longitudinal social network analysis research on Native mothers navigating substance use disorder and perinatal care. The University of Utah, through its Office of Sponsored Projects Division, will characterize the social networks of...
- The National Institute on Drug Abuse awarded the University of Oregon $731,194 on May 15, 2026, to conduct a micro-randomized trial testing mobile app-based just-in-time interventions for simultaneous alcohol and cannabis use among young adults under the Drug Use and Addiction Research Programs (CFDA 93.279). The research will develop and refine digital mindfulness-based and protective behavioral strategy intervention content, then deploy it through a randomized trial with daily-level...
- The National Institute on Drug Abuse awarded The University of Iowa $537,469 on August 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to investigate carbonic anhydrase 4 as a non-opioid therapeutic target for reversing opioid-induced neurobiological changes underlying relapse and drug-seeking behavior. The research employs a multidisciplinary approach in mice to delineate synaptic, circuit, and network-level mechanisms through which carbonic anhydrase 4 disruption and...
- The National Institute on Drug Abuse awarded New York University $547,333 on September 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct a mixed-methods study identifying state-level implementation strategies for expanding access to extended take-home methadone doses in opioid treatment programs. The award funds a phased R61/R33 project examining how state agencies—including state opioid treatment authorities and Medicaid agencies—are facilitating adoption of...
- The National Institute on Drug Abuse awarded Loyola University of Chicago Health Sciences Campus $551,926 on May 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct a large-scale longitudinal epidemiological study of polysubstance use and associated health outcomes. The recipient will leverage the Oracle EHR Real-World Data database, comprising 1.9 billion encounters from 113 million patients across 700 U.S. hospitals and clinics, to conduct four primary...